Monte Rosa Therapeutics Stock Return On Equity
| GLUE Stock | USD 5.65 0.05 0.89% |
Monte Rosa Therapeutics fundamentals help investors to digest information that contributes to Monte Rosa's financial success or failures. It also enables traders to predict the movement of Monte Stock. The fundamental analysis module provides a way to measure Monte Rosa's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Monte Rosa stock.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (0.76) | (0.72) |
Monte | Return On Equity |
Monte Rosa Therapeutics Company Return On Equity Analysis
Monte Rosa's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Monte Rosa Return On Equity | -0.6 |
Most of Monte Rosa's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Monte Rosa Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Monte Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Monte Rosa is extremely important. It helps to project a fair market value of Monte Stock properly, considering its historical fundamentals such as Return On Equity. Since Monte Rosa's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Monte Rosa's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Monte Rosa's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Monte Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Monte Rosa Therapeutics has a Return On Equity of -0.6007. This is 97.49% lower than that of the Biotechnology sector and 98.35% lower than that of the Health Care industry. The return on equity for all United States stocks is 93.77% higher than that of the company.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Monte Fundamentals
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.28 | ||||
| Current Valuation | 96.91 M | ||||
| Shares Outstanding | 50.15 M | ||||
| Shares Owned By Insiders | 0.86 % | ||||
| Shares Owned By Institutions | 98.16 % | ||||
| Number Of Shares Shorted | 1.87 M | ||||
| Price To Earning | 1.91 X | ||||
| Price To Book | 2.01 X | ||||
| EBITDA | (137.09 M) | ||||
| Net Income | (135.35 M) | ||||
| Cash And Equivalents | 294.14 M | ||||
| Cash Per Share | 6.32 X | ||||
| Total Debt | 46.04 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 20.11 X | ||||
| Book Value Per Share | 3.58 X | ||||
| Cash Flow From Operations | (43.8 M) | ||||
| Short Ratio | 11.37 X | ||||
| Earnings Per Share | (2.63) X | ||||
| Target Price | 16.5 | ||||
| Number Of Employees | 133 | ||||
| Beta | 1.45 | ||||
| Market Capitalization | 284.34 M | ||||
| Total Asset | 303.75 M | ||||
| Retained Earnings | (365.89 M) | ||||
| Working Capital | 189.62 M | ||||
| Net Asset | 303.75 M |
About Monte Rosa Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Monte Rosa Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Monte Rosa using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Monte Rosa Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Monte Rosa in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Monte Rosa's short interest history, or implied volatility extrapolated from Monte Rosa options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Monte Rosa Piotroski F Score and Monte Rosa Altman Z Score analysis. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Monte Stock analysis
When running Monte Rosa's price analysis, check to measure Monte Rosa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Monte Rosa is operating at the current time. Most of Monte Rosa's value examination focuses on studying past and present price action to predict the probability of Monte Rosa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Monte Rosa's price. Additionally, you may evaluate how the addition of Monte Rosa to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Monte Rosa's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monte Rosa. If investors know Monte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monte Rosa listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.63) | Return On Assets (0.28) | Return On Equity (0.60) |
The market value of Monte Rosa Therapeutics is measured differently than its book value, which is the value of Monte that is recorded on the company's balance sheet. Investors also form their own opinion of Monte Rosa's value that differs from its market value or its book value, called intrinsic value, which is Monte Rosa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monte Rosa's market value can be influenced by many factors that don't directly affect Monte Rosa's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monte Rosa's value and its price as these two are different measures arrived at by different means. Investors typically determine if Monte Rosa is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monte Rosa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.